Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia

Hematology Am Soc Hematol Educ Program. 2011:2011:231-7. doi: 10.1182/asheducation-2011.1.231.

Abstract

The author discusses both the standards of care and more controversial areas in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Publication types

  • Review

MeSH terms

  • Drug Resistance, Neoplasm / drug effects
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Philadelphia Chromosome*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use
  • Remission Induction

Substances

  • Protein Kinase Inhibitors